Compare PROP & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROP | PRPO |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.9M | 38.3M |
| IPO Year | 2008 | 2000 |
| Metric | PROP | PRPO |
|---|---|---|
| Price | $0.31 | $18.52 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 23.9K |
| Earning Date | 11-12-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 49.06 | ★ 92.15 |
| EPS | ★ N/A | N/A |
| Revenue | $7,939,000.00 | ★ $24,049,000.00 |
| Revenue This Year | $85.81 | $233.72 |
| Revenue Next Year | $11.47 | $22.61 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 413.59 | 29.77 |
| 52 Week Low | $0.30 | $17.79 |
| 52 Week High | $2.55 | $33.63 |
| Indicator | PROP | PRPO |
|---|---|---|
| Relative Strength Index (RSI) | 36.77 | 42.45 |
| Support Level | N/A | $18.51 |
| Resistance Level | $0.44 | $24.89 |
| Average True Range (ATR) | 0.05 | 1.93 |
| MACD | -0.01 | 0.11 |
| Stochastic Oscillator | 2.94 | 20.66 |
Prairie Operating Co is an independent oil and natural gas company focused on the acquisition and development of crude oil, natural gas, and natural gas liquids (NGLs). Its assets and operations are located in the oil region of rural Weld County, Colorado, within the Denver-Julesburg Basin in Colorado (the DJ Basin). The company generates maximum revenue from crude oil sales, and the rest from the sale of natural gas and natural gas liquids.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.